Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ.

Am J Psychiatry. 2006 Sep;163(9):1519-30; quiz 1665.

PMID:
16946176
2.

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.

Am J Psychiatry. 2006 Jul;163(7):1161-72.

PMID:
16816220
3.

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.

Am J Psychiatry. 2006 Sep;163(9):1531-41; quiz 1666.

PMID:
16946177
4.

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.

Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen B.

Am J Psychiatry. 2000 Sep;157(9):1429-35.

PMID:
10964859
5.

STAR*D: revising conventional wisdom.

Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA.

CNS Drugs. 2009 Aug;23(8):627-47. doi: 10.2165/00023210-200923080-00001.

PMID:
19594193
6.

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH.

Am J Psychiatry. 2008 Mar;165(3):342-51. doi: 10.1176/appi.ajp.2007.06111868. Epub 2008 Jan 2.

PMID:
18172020
7.
8.

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH.

Int J Neuropsychopharmacol. 2009 May;12(4):459-73. doi: 10.1017/S1461145708009073. Epub 2008 Jul 9.

PMID:
18611293
9.

Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

Alevizos B, Alevizos E, Leonardou A, Zervas I.

Psychiatriki. 2012 Apr-Jun;23(2):143-8.

PMID:
22796912
10.

Treatment of antidepressant nonresponders: augmentation or switch?

Nelson JC.

J Clin Psychiatry. 1998;59 Suppl 15:35-41. Review.

11.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
12.

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ.

Am J Psychiatry. 2007 May;164(5):739-52.

PMID:
17475733
13.
14.

Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients.

Posternak MA, Zimmerman M.

J Clin Psychiatry. 2001 Feb;62(2):135-42; quiz 143.

PMID:
11247104
15.

Adding lithium to antidepressant therapy: factors related to therapeutic potentiation.

Rybakowski J, Matkowski K.

Eur Neuropsychopharmacol. 1992 Jun;2(2):161-5.

PMID:
1633434
16.
17.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
18.

Should thyroid augmentation precede lithium augmentation--a pilot study.

Spoov J, Lahdelma L.

J Affect Disord. 1998 Jun;49(3):235-9.

PMID:
9629954
19.

Cognitive therapy vs medications in the treatment of moderate to severe depression.

DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R.

Arch Gen Psychiatry. 2005 Apr;62(4):409-16.

PMID:
15809408
20.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669

Supplemental Content

Support Center